Back to Journals » International Journal of Nanomedicine » Volume 13

Transferrin receptor-targeted HMSN for sorafenib delivery in refractory differentiated thyroid cancer therapy

Total article views   HTML views PDF downloads Totals
6,654 Dovepress* 5,740+ 1,115 6,855
PubMed Central* 914 283 1,197
Totals 6,654 1,398 8,052
*Since 6 December 2018

View citations on PubMed Central and Google Scholar